Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1 clinical trial of BLU-782 in healthy volunteers

Trial Profile

Phase 1 clinical trial of BLU-782 in healthy volunteers

Planning
Phase of Trial: Phase I

Latest Information Update: 04 Jan 2019

At a glance

  • Drugs BLU-782 (Primary)
  • Indications Fibrodysplasia ossificans progressiva
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Jan 2019 According to a Blueprint Medicines media release, this trial is anticipated to begin in the first half of 2020.
    • 08 Oct 2018 New trial record
    • 01 Oct 2018 According to a Blueprint Medicines media release, company expects to submit an investigational new drug (IND) by the end of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top